AlphaCrest Capital Management’s Avanos Medical AVNS Stock Holding History

AlphaCrest Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-90,110	Closed	-$1.96M	–	106
2022 Q3	$1.96M	Buy	90,110 +54,985	+157%	+$1.44M	0.12%	240
2022 Q2	$960K	Sell	35,125 -44,537	-56%	-$1.28M	0.05%	677
2022 Q1	$2.67M	Buy	79,662 +21,917	+38%	+$706K	0.15%	151
2021 Q4	$2M	Buy	57,745 +30,767	+114%	+$995K	0.07%	433
2021 Q3	$842K	Sell	26,978 -737	-3%	-$25K	0.04%	685
2021 Q2	$1.01M	Buy	27,715 +19,015	+219%	+$786K	0.04%	660
2021 Q1	$381K	Sell	8,700 -1,300	-13%	-$61K	0.02%	923
2020 Q4	$459K	Buy	+10,000	New	+$416K	0.04%	700

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's AVNS Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Avanos Medical (AVNS) in Q4 2022, closing a stake of 90,110 shares — an estimated $1.96M sold.

AlphaCrest Capital Management first reported a position in AVNS in Q4 2020 and held it in 8 quarters. The position peaked at $2.67M in Q1 2022. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

AlphaCrest Capital Management reported no remaining Avanos Medical position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 90,110 Avanos Medical shares in Q4 2022, an estimated $1.96M.
AlphaCrest Capital Management first reported a position in Avanos Medical in Q4 2020 and held it in 8 quarters.
AlphaCrest Capital Management's Avanos Medical position peaked at $2.67M in Q1 2022.
288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.